Advanced LifeSciences Confirms Efficacy Of Cethromycin In Second Phase III Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Company now intends to focus on filing an NDA in community-acquired pneumonia and seeking a marketing partner for the product.